NewsletterPatrys Investor Newsletter22 Jun 20220Our latest Investor Newsletter is here. This edition includes an update from Patrys CEO and MD, Dr James Campbell; a…
MediaPatrys on Channel 7 News20 Jun 20220Channel 7 News Journalist Jackie Quist recently interviewed Patrys CEO and MD, Dr James Campbell, together with Telethon Kids Institute’s,…
ASX AnnouncementsPAT-DX1 Significantly Improves Survival in Animal Model of Pancreatic Cancer14 Jun 20220Patrys has today announced the publication of new data from a series of studies by our collaborators Dr James Hansen,…
ASX AnnouncementsCure Brain Cancer Foundation Research Grant3 Jun 20220Patrys is pleased to share news that the Telethon Kids Institute has been awarded significant funding from the Cure Brain…
MediaMergermarket | Interview with Dr James Campbell30 May 20220Patrys CEO and MD, Dr James Campbell, was recently interviewed by Louise Weihart at Mergermarket, to discuss the deal potential…
MediaABC NEWS | May 20229 May 20220Patrys CEO and Managing Director, Dr James Campbell, is presenting at the 16th Bioshares Biotech Summit to be hosted in…
ASX AnnouncementsQuarterly Activities Report and 4C28 Apr 20220Patrys has published its Quarterly Activities Report and 4C Quarterly Cash Flow Report. Highlights for this Quarter have included: Work…
ASX AnnouncementsPatrys strengthens executive team26 Apr 20220Patrys today announced the appointment of Dr Rebecca Tunstall to the role of Vice President, Corporate Development. As a key…
News UpdateNew research: Scientists determine structure of a DNA damage ‘First Responder’ protein23 Mar 20220Scientists at the Sloan Kettering Institute have debunked a 20-year guiding paradigm for how the 9-1-1 clamp – a protein…
MediaVideoVIDEO | Dr James Campbell on Proactive28 Feb 20220Patrys CEO and MD, Dr James Campbell, was interviewed by Proactive’s Andrew Scott today to discuss the importance of the…